Abstract
This chapter provides a contextualisation of policy developments in the biosciences, health-research and information governance in relation to societal tendencies. The initiatives considered include the Clinical Research Practice Datalink, the Health and Social Care Information Centre, the 100,000 Genome Project, the introduction of personalised medicine, and the relaxation of the information governance regulatory regime. It is argued that we are witnessing a shift from rights-based approach to the adjudication of competing claims, in which benefits to the economy, for example, are seen as goods to be balanced with a data subject’s right to privacy and confidentiality. The greater weight that economic interests now possess in information governance and the biosciences has substantive implications for future policy in this area. This, along with the new powers of access by the Government, moves us into unexplored terrain and generates novel ethical challenges. Though, this chapter advocates an approach to policy and governance that proceeds along deliberative and democratic lines, the developments of concern to this chapter are evidence of the challenges that lie ahead.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Except for an “important public interest reason in cases restrictively provided for by domestic law consistent with the international law of human rights or where the prior, free, informed consent of the person concerned.”
References
Brown, Wendy. 2006. American Nightmare Neoliberalism, Neoconservatism, and De-Democratization. Polit Theo 34(6): 690–714.
Caulfield, Timothy. 1999. Regulating the commercialisation of human genetics. Can we address the big concerns? In Genetic information. Acquisition, access, and control, ed. A. Thompson and R. Chadwick, 149–162. New York: Kluwer Academic/Plenum Publishers.
Caulfield, Timothy, Ross Upshur, and Abdallah Daar. 2003. DNA databanks and consent: A suggested policy option involving an authorization model. BMC Medical Ethics 4: 1.
Chadwick, Ruth. 2011. The communitarian turn: Myth or reality? Cambridge Quarterly of Healthcare Ethics 20(4): 546–553.
Chadwick, Ruth, and Kåre Berg. 2001. Solidarity and equity: New ethical frameworks for genetic databases. Nature review. Genetics. 2: 320.
Chadwick, Ruth, and Adam Hedgecoe. 2002. Commercialisation of the human genome. In A companion to genethics, ed. J. Burley and J. Harris. Oxford: Blackwell.
Department of Health. 2012. Building on our inheritance: Genomic technology in healthcare. https://www.gov.uk/government/publications/genomic-technology-in-healthcare-building-on-our-inheritance. Accessed 11 June 2014.
Department of Health. UK Gov. 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/210830/ethics_advice_letter_to_CMO.pdf. Accessed 24 Nov 2014.
Ethics Advisory Group. 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/210830/ethics_advice_letter_to_CMO.pdf. Accessed 7 Mar 2015.
Everyone ‘to be research patient’, says David Cameron. 2011. BBC News, December 5.
Evidence submitted by the Association of the British Pharmaceutical. 2007. Industry Select Committee on Health Written Evidence. House of Commons Select Committees. http://www.publications.parliament.uk/pa/cm200607/cmselect/cmhealth/422/422we05.htm. Accessed 27 June 2014.
Finlayson, Gordon. 2000. Modernity and morality in Habermas’s discourse ethics, inquiry: An interdisciplinary. Journal of Philosophy 43(3): 319–340.
Genomics England. 2013. http://www.genomicsengland.co.uk/genomics-england-launch/. Accessed 15 Mar 2015.
Genomics England. 2014. http://www.genomicsengland.co.uk/prof-mike-parker-says-no-ethical-issues-are-off-the-table-as-gel-considers-its-approach-to-patient-consent/. Accessed 10 Mar 2014.
Goffman, Erving. 1986. Frame analysis. Reprint. Boston: Northeastern University Press.
Gray, Richard. 2013. Children could have DNA tested at birth 2013. Telegraph, December 8.
Gunson, D. 2010. The philosophical foundations of the discourse society. In Oppositional discourses, ed. M. Huspek. Oxford: Routledge.
Habermas, Jürgen. 1984. The theory of communicative action, vol. 1: Reason and the rationalization of society. London: Heinemann.
Habermas, Jürgen. 1987. The theory of communicative action, vol. 2: Lifeworld and system: A critique of functionalist reason. Oxford: Polity Press.
Habermas, Jürgen. 1990. Moral consciousness and communicative action. Cambridge: Polity Press.
Habermas, Jürgen. 1996. Between facts and norms. Cambridge: Polity Press.
Habermas, Jürgen. 2015. The lure of technocracy. Cambridge: Polity Press.
Heeney, C., N. Hawkins, J. de Vries, P. Boddington, and J. Kaye. 2011. Assessing the privacy risks of data sharing in genomics. Public Health Genomics 14(1): 17–25. doi:10.1159/000294150.
Ingram, David. 2012. Habermas: Introduction and analysis. Ithaca: Cornell University Press.
Knoppers, Bartha. 2005. Biobanking: International norms. The Journal of Law Medicine and Ethics 33(1): 7–14.
Knoppers, Bartha, and Ruth Chadwick. 1994. The Human Genome Project: Under an international ethical microscope. Science 2035–2036.
Lunshof, Jeantine E., Chadwick Ruth, B. Vorhaus Daniel, and M. Church George. 2008. From genetic privacy to open consent. Nat Rev Genet 9(5): 406–411.
Mittelstadt, Brent Daniel, and Luciano Floridi. 2016. The ethics of Big Data: Current and foreseeable issues in biomedical contexts. Science and Engineering Ethics 22(2): 303–341. doi:10.1007/s11948-015-9652-2.
Mudge, Stephanie. 2008. What is neo-liberalism? Socio-Economic Review 6(4): 703–731.
Murphy, Elisabeth. 2013. Inside 23andme founder Anne Wojcicki’s $99 DNA revolution. Fast Company. http://www.fastcompany.com/3018598/for-99-this-ceo-can-tell-you-what-might-kill-you-inside-23andme-founder-anne-wojcickis-dna-r. Accessed 13 May 2014.
NHS England. 2014. http://www.england.nhs.uk/2014/07/03/genomic-medicine/. Accessed 19 June 2015.
Nuffield Council on Bioethics. 2012. Emerging biotechnologies: Technology, choice and the public good. http://nuffieldbioethics.org/wpcontent/uploads/2014/07/Emerging_biotechnologies_full_report_web_0.pdf. Accessed 21 Mar 2015.
Nuffield Council on Bioethics. 2015. The collection, linking and use of data in biomedical research and health care: Ethical issues. http://nuffieldbioethics.org/wp-content/uploads/Biological_and_health_data_web.pdf. Accessed 21 Mar 2015.
Ramesh, Randeep. 2014. NHS patient data to be made available for sale to drug and insurance firms. Guardian, January 19.
Sample, Ian. 2012. NHS patient records to revolutionise medical research in Britain. Guardian, August 28.
Sandel, Michael. 2012. What money can’t buy: The moral limits of market. New York: Farrar, Straus and Giroux.
Sturgis, Patrick. 2014. On the limits of public engagement for the governance of emerging technologies. Public Understanding of Science 23(1): 38–42.
United Nations Educational, Scientific and Cultural Organization (UNESCO). 2015. Global bioethics: What for? http://unesdoc.unesco.org/images/0023/002311/231159e.pdf. Accessed 12 Mar.
United Nations Educational Social Cultural Organisation. 2003. International declaration on human genetic data. http://unesdoc.unesco.org/images/0013/001331/133171e.pdf#page=45. Accessed 5 Sept 2015.
United Nations Educational Social Cultural Organisation. 2005. Universal Declaration on Bioethics and Human Rights. http://unesdoc.unesco.org/images/0014/001461/146180E.pdf. Accessed 27 Feb 2015.
United Nations Office of the High Commissioner for Human Rights. 1998. The Universal Declaration on the Human Genome and Human Rights. http://www.ohchr.org/EN/ProfessionalInterest/Pages/HumanGenomeAndHumanRights.asp. Accessed 22 Apr 2015.
Walker, Peter. 2012. DNA of 100,000 people to be mapped for NHS. Guardian, December 10.
Wilsdon, James, and Rebecca Willis. 2004. See through science: Why public engagement needs to move upstream. DEMOS. http://www.demos.co.uk/files/Seethroughsciencefinal.pdf. Accessed 19 May 2015.
Written Evidence Letter from SmithKline Beecham. 2000. Select Committee on Science and Technology. http://www.publications.parliament.uk/pa/ld199900/ldselect/ldsctech/115/115we45.htm. Accessed 25 Mar 2015.
Written Evidence Memorandum by Glaxo Wellcome. 2000. Select Committee on Science and Technology. http://www.publications.parliament.uk/pa/ld199900/ldselect/ldsctech/115/115we24.htm. Accessed 12 May 2015.
Wynne, Brian. 2011. Lab work goes social, and vice versa: Strategising public engagement processes. Science and Engineering Ethics 17(4): 791–800.
Younger Committee. 1972. Report of the committee on privacy, Cmnd. 5012. London: HMSO.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hockings, E. (2016). A Critical Examination of Policy-Developments in Information Governance and the Biosciences. In: Mittelstadt, B., Floridi, L. (eds) The Ethics of Biomedical Big Data. Law, Governance and Technology Series, vol 29. Springer, Cham. https://doi.org/10.1007/978-3-319-33525-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-33525-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33523-0
Online ISBN: 978-3-319-33525-4
eBook Packages: Religion and PhilosophyPhilosophy and Religion (R0)